News

Completion of Innovate UK Smart Award

01 April 2015

April 2015 Oval Medical completes Innovate UK (formerly The Technology Strategy Board) Smart Award Grant for development of manufacturing equipment for their novel container closure system. Oval Medical has developed…

More...

Rights Issue

01 March 2015

March 2015 Oval Medical recently completed a £1.5m rights issue for the development of the manufacturing process for its novel autoinjector. The autoinjector facilitates the delivery of the new generation…

More...

Oval Medical awarded Innovate UK Proof of Market funding award

01 November 2014

November 2014 Oval Medical received £25,000 to contribute to market research for its new, innovative epinephrine autoinjector for the treatment of anaphylactic shock. The incidence of allergies that can cause…

More...

Oval and SOLIZE enter into collaboration on injection device development

28 April 2014

Press Release For Immediate Release Cambridge, UK. Monday, 28 April 2014 – Oval Medical Technologies Limited (“Oval”) Oval and SOLIZE enter into collaboration on injection device development. Working together to…

More...

Technology Strategy Board – Smart Funding Award

16 April 2014

Press Release For Immediate Release Oval Medical awarded Technology Strategy Board Smart funding award Cambridge, UK. 14 April 2014 – Oval Medical Technologies Limited (“Oval”) announced today they have received…

More...

Oval’s technology features in Cambridge University paper exploring inclusive design

28 January 2014

Inclusive design has unique challenges because it aims to improve usability for a wide range of users. This typically includes people with lower levels of ability, as well as mainstream…

More...

Oval Medical secures £1 million deal with US pharmaceutical company

26 July 2013

Oval Medical Technologies Ltd (‘Oval’) today announced that they have signed another deal following an initial feasibility study with a global pharmaceutical company, to a value in excess of one…

More...

Oval Medical appoints new CEO

06 June 2013

The board of Oval Medical Technologies Limited (‘Oval’) announces that effective from 1st May 2013, Barbara Lead has succeeded Dr Catherine Beech as Chief Executive Officer of Oval Medical Technologies…

More...

Oval Medical announces the availability of functional prototypes

30 May 2013

30th May 2013 – Oval Medical Technologies Ltd (‘Oval’), today have announced that functional prototypes of their autoinjector technology are now available. Oval’s specification for a standard 1ml device was…

More...

Revolutionary autoinjector pushes the limits of high viscosity drug delivery

17 April 2013

17th April 2013 – Oval Medical Technologies Ltd (‘Oval’), today have announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a…

More...